These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 10895170)
1. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 3. Comparative study of early mucosal reaction and late tongue atrophy between LDR and HDR Ir-192 interstitial brachytherapy for patients with carcinoma of the mobile tongue. Inoue T; Inoue T; Yoshioka Y; Yoshida K Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():296-300. PubMed ID: 10895170 [No Abstract] [Full Text] [Related]
2. High dose rate interstitial brachytherapy for mobile tongue cancer: Part 1. Phase I/II study of HDR hyperfractionated interstitial brachytherapy for oral cancer. Inoue T; Inoue T; Teshima T Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():287-90. PubMed ID: 10895168 [No Abstract] [Full Text] [Related]
3. High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 2. Phase III trial of HDR versus LDR interstitial brachytherapy for T1-T2N0 carcinoma of the mobile tongue. Inoue T; Inoue T Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():291-5. PubMed ID: 10895169 [No Abstract] [Full Text] [Related]
5. A comparison of brachytherapy and surgery for the treatment of stage I-II squamous cell carcinoma of the tongue. Umeda M; Komatsubara H; Ojima Y; Minamikawa T; Shibuya Y; Yokoo S; Ishii J; Komori T Int J Oral Maxillofac Surg; 2005 Oct; 34(7):739-44. PubMed ID: 15921890 [TBL] [Abstract][Full Text] [Related]
6. Long-term functional outcome of brachytherapy for carcinoma of the mobile tongue: focus on the atrophic change of irradiated tongue. Urashima Y; Nakamura K; Shioyama Y; Sasaki T; Ohga S; Toba T; Kunitake N; Chikui T; Kawazu T; Yamada T; Terashima H; Honda H Jpn J Clin Oncol; 2006 Nov; 36(11):681-7. PubMed ID: 17020894 [TBL] [Abstract][Full Text] [Related]
7. Late effects of post-high-dose-rate brachytherapy for oropharyngeal carcinoma: are they severer than post-low-dose-rate? Nose T; Peiffert D; Lapeyre M; Hoffstetter S; Koizumi M; Nishiyama K Strahlenther Onkol; 2004 Dec; 180(12):776-82. PubMed ID: 15592697 [TBL] [Abstract][Full Text] [Related]
8. High-dose-rate interstitial brachytherapy for mobile tongue cancer: influence of the non-irradiated period. Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K Anticancer Res; 2006; 26(5B):3933-7. PubMed ID: 17094424 [TBL] [Abstract][Full Text] [Related]
9. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma. Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696 [TBL] [Abstract][Full Text] [Related]
10. Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma. Bourgier C; Coche-Déquéant B; Fournier C; Castelain B; Prévost B; Lefebvre JL; Lartigau E Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):434-40. PubMed ID: 16168836 [TBL] [Abstract][Full Text] [Related]
11. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis. Takácsi-Nagy Z; Oberna F; Polgár C; Somogyi A; Major T; Németh G Neoplasma; 2001; 48(1):76-81. PubMed ID: 11327543 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of high-dose-rate interstitial brachytherapy in patients with oral tongue carcinoma. Guinot JL; Santos M; Tortajada MI; Carrascosa M; Estellés E; Vendrell JB; Muelas R; Chust ML; Mengual JL; Arribas L Brachytherapy; 2010; 9(3):227-34. PubMed ID: 20116340 [TBL] [Abstract][Full Text] [Related]
13. Quantitative evaluation of acute mucosal reaction to interstitial brachytherapy using color histograms. Yoshida K; Nose T; Watanabe Y; Tokuda Y; Choi S; Hosoki T; Mitomo M; Inaba O; Iida T; Okada H Brachytherapy; 2005; 4(4):298-303. PubMed ID: 16344261 [TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation based on cost-effectiveness]. Inoue T; Inoue T Gan To Kagaku Ryoho; 1998 Jan; 25(1):13-9. PubMed ID: 9464324 [TBL] [Abstract][Full Text] [Related]
15. [Apropos of failure of exclusive high dose rate interstitial brachytherapy in squamous cell carcinoma of the mobile tongue]. Mazeron JJ; Gerbaulet A Bull Cancer Radiother; 1996; 83(3):172-3. PubMed ID: 8977569 [No Abstract] [Full Text] [Related]
16. [Present and future in brachytherapy--from the discovery of radium to the 21st century]. Inoue T; Inoue T Gan To Kagaku Ryoho; 1999 Aug; 26(9):1254-60. PubMed ID: 10478177 [TBL] [Abstract][Full Text] [Related]
17. [The interstitial radiation therapy of cancer of the tongue and mucosa of the floor of the mouth]. Zamiatin OA; Vakhramova MP; Razorenova EV Vopr Onkol; 1995; 41(2):112-4. PubMed ID: 7483404 [No Abstract] [Full Text] [Related]
18. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587 [TBL] [Abstract][Full Text] [Related]
19. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer. Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473 [TBL] [Abstract][Full Text] [Related]
20. [Brachytherapy--carcinoma of the tongue]. Jingu K; Hayabuchi N; Matsui M; Wada S; Miyoshi M; Uehara S; Shimamura Y; Hirata H; Ariji E; Moriguchi S Gan No Rinsho; 1987 Oct; 33(13):1609-18. PubMed ID: 3694797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]